| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/22/2014 | CN103534250A Substituted indole derivatives for the treatment of immunological disorders |
| 01/22/2014 | CN103534249A Novel rock inhibitors |
| 01/22/2014 | CN103534248A Process for the preparation of anhydrous aripiprazole crystal form ii |
| 01/22/2014 | CN103534241A Fak抑制剂 Fak inhibitors |
| 01/22/2014 | CN103534240A Selective FAK inhibitors |
| 01/22/2014 | CN103534239A Substituted indazole derivatives active as kinase inhibitors |
| 01/22/2014 | CN103524495A Process for preparing 2, 3-disubstituted indoles |
| 01/22/2014 | CN103524494A Sulfydryl imidazole derivative comprising picoline group and synthetic method |
| 01/22/2014 | CN103524493A Nicosulfuron preparation method |
| 01/22/2014 | CN103524492A Quinolones compound with side chain containing nitroimidazole group substitution as well as preparation and use thereof |
| 01/22/2014 | CN103524491A Three crystal forms of esomeprazole magnesium salt tetrahydrate and preparation method thereof |
| 01/22/2014 | CN103524490A Crystallization method for preparing amorphous esomeprazole magnesium salt |
| 01/22/2014 | CN103524489A Synthesis process of 2-chlorin-5-((2-(nitryl methylene) imidazoline-1-yl) methyl) pyridine |
| 01/22/2014 | CN103524488A 1-(6-bromopyridine)-5-hydroxyl-1-hydrogen-pyrozolyl-3-methyl formate and synthetic method thereof |
| 01/22/2014 | CN103524487A Sitafloxacin preparation method |
| 01/22/2014 | CN103524486A N-quinolyl substituted beta-lactam compound, as well as pharmaceutical composition, synthetic method and application of compound |
| 01/22/2014 | CN103524485A Method for continuously synthesizing imazethapyr |
| 01/22/2014 | CN103524484A Production method of solid nicotine |
| 01/22/2014 | CN103524483A Preparation method of alogliptin benzoate |
| 01/22/2014 | CN103524436A 1-[(3-alkoxy-6-substituted-quinoxalin-2-yl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives |
| 01/22/2014 | CN103524432A Method for preparing 2,3-dihydroquinazoline-4(3H)-ketone derivatives |
| 01/22/2014 | CN103524430A 4-(trans-4-substituted-3-butylene-1-alkynyl)-4-trifluoromethyl-3,4-dihydro substituted quinazoline-2(1H)-ketone compounds, and preparation method and application thereof |
| 01/22/2014 | CN103524420A Keratin dyeing compounds, keratin dyeing compositions containing said compounds, and use thereof |
| 01/22/2014 | CN103524419A Group of 3-trifluoromethyl pyrazole compounds |
| 01/22/2014 | CN103524418A 3-methyl pyrazol compounds |
| 01/22/2014 | CN103524413A Hydrogenated acridine derivative and application thereof |
| 01/22/2014 | CN103524407A 2-fluorine-3-pyridine formyl compounds |
| 01/22/2014 | CN103524398A Naphthalene-based high condensed ring-aza [6] helicene compound and synthesis method thereof |
| 01/22/2014 | CN103524392A Azetidines as mek inhibitors for the treatment of proliferative diseases |
| 01/22/2014 | CN103524372A Novel histone deacetylase inhibitor |
| 01/22/2014 | CN103521267A N2-substituted-1,2,3-triazole ligand auxiliary Cu (I) catalysts and applications thereof |
| 01/22/2014 | CN103518745A Dialdehyde-built nitrogen-containing or oxygen-containing heterocyclic compound with insecticidal activity and preparation method thereof |
| 01/22/2014 | CN102827146B Fluoroquinolone acetal ftivazide as well as preparation method and application thereof |
| 01/22/2014 | CN102753540B A4ss2 neuronal nicotinic acetylcholine receptor ligands |
| 01/22/2014 | CN102659763B Method for synthesizing and purifying dexlansoprazole |
| 01/22/2014 | CN102633779B Fasudil acetate as well as preparation method and application thereof |
| 01/22/2014 | CN102617451B Pipradrol derivatives with pesticidal activity as well as preparation and application thereof |
| 01/22/2014 | CN102491972B Carbazole derivative, preparation method thereof, and application of carbazole derivative serving as anticancer drug |
| 01/22/2014 | CN102124001B Derivatives of 2-oxo-alkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same |
| 01/22/2014 | CN102112451B Diazepan and piperazine derivatives modulators of chemokine receptors |
| 01/22/2014 | CN102083811B 2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors |
| 01/22/2014 | CN101910153B Pyrimidines as kinase inhibitors |
| 01/22/2014 | CN101812054B 1-acetyl-N-phenyl-N-(3-(4-(3-phenyl-1-H-pyrazole-5-radial)piperidine-1-radical)propyl)-4-amide derivative and preparation method thereof |
| 01/21/2014 | US8633224 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 01/21/2014 | US8633223 Process for preparation of 2-methyl-2′-phenylpropionic acid derivatives and novel intermediate compounds |
| 01/21/2014 | US8633222 Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 01/21/2014 | US8633219 Combination therapy |
| 01/21/2014 | US8633214 Spiro (piperidine-4,2′-pyrrolidine)-1-(3,5-trifluoromethylphenyl) methylcarboxamides as NK1 tachikynin receptor antagonists |
| 01/21/2014 | US8633210 Triazole compounds useful as protein kinase inhibitors |
| 01/21/2014 | US8633209 Hydrobromide salts of a pyrazolylaminoquinazoline |
| 01/21/2014 | US8633208 6-1H-imidazo-quinazoline and quinolines derivatives, new MAO inhibitors and imidazoline receptor ligands |
| 01/21/2014 | US8633207 Quinazoline compounds and methods of use thereof |
| 01/21/2014 | US8633190 Spirolactam derivatives and uses of same |
| 01/21/2014 | CA2691442C Antiviral compounds |
| 01/21/2014 | CA2622000C Quinolines and their therapeutic use |
| 01/21/2014 | CA2609288C Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor xa inhibitors |
| 01/21/2014 | CA2605050C Histone deacetylase inhibitors |
| 01/21/2014 | CA2515116C Amino-1,3,5-triazines n-substituted with chiral bicyclic radicals, process for their preparation, compositions thereof, and their use as herbicides and plant growth regulators |
| 01/16/2014 | WO2014011005A1 Cyanine fluorescent probe, method for detecting zinc ion using same and method for preparing same |
| 01/16/2014 | WO2014010990A1 Novel pyridine derivatives and method for preparation of intermediate compound for producing sulfonylurea herbicides using the same |
| 01/16/2014 | WO2014010810A1 Novel compound and electroluminescent device including same |
| 01/16/2014 | WO2014010748A1 Cyclopropane derivative having bace1 inhibiting activity |
| 01/16/2014 | WO2014009495A1 Antiproliferative benzo [b] azepin- 2 - ones |
| 01/16/2014 | WO2014008992A1 Pyrimidine pyrazolyl derivatives |
| 01/16/2014 | WO2014008794A1 Crystalline form i of tyrosine kinase inhibitor dimaleate and preparation methods thereof |
| 01/16/2014 | US20140018541 Umsymmetrical bisazides for chemoselective sequential ligation |
| 01/16/2014 | US20140018537 Gpr119 agonist |
| 01/16/2014 | US20140018396 Combination of sulfonamide compound |
| 01/16/2014 | US20140018394 5-lipoxgenase-activating protein (flap) inhibitors |
| 01/16/2014 | US20140018391 Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content |
| 01/16/2014 | US20140018389 Hepatitis C Virus Inhibitors |
| 01/16/2014 | US20140018380 Bicyclic heteroaryl compounds as gpr119 receptor agonists |
| 01/16/2014 | US20140018371 Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
| 01/16/2014 | US20140018370 Apoptosis signal-regulating kinase inhibitors |
| 01/16/2014 | US20140018368 Hedgehog antagonists having zinc binding moieties |
| 01/16/2014 | US20140018365 Pharmaceutically active compounds as axl inhibitors |
| 01/16/2014 | US20140018335 Indole derivative, and pharmacologically acceptable salt thereof |
| 01/16/2014 | US20140018318 N1- and N2-CARBAMOYL-1,2,3-TRIAZOLE SERINE HYDROLASE INHIBITORS AND METHODS |
| 01/16/2014 | CA2877187A1 Antiproliferative benzo [b]azepin-2-ones |
| 01/16/2014 | CA2876884A1 Crystalline form i of tyrosine kinase inhibitor dimaleate and preparation methods thereof |
| 01/15/2014 | EP2684878A1 Dipyridylamine derivative |
| 01/15/2014 | EP2684877A2 Pharmaceutically acceptable salt of (e)-n-[4-[[3-chloro-4-(2-pyridylmethoxy)phenyl]amino]-3-cyano-7-ethoxy-6-quinolyl]-3-[(2r)-1-methylpyrrolidin-2-yl]prop-2-enamide, preparation method therefor, and medical use thereof |
| 01/15/2014 | EP2684871A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives |
| 01/15/2014 | EP2683712A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 01/15/2014 | EP2683711A1 New pyridazinone and pyridone compounds |
| 01/15/2014 | EP2683710A1 Soluble guanylate cyclase activators |
| 01/15/2014 | EP2683709A1 Pyridinyl- and pyrazinyl -methyloxy - aryl derivatives useful as inhibitors of spleen tyrosine kinase (syk) |
| 01/15/2014 | EP2683708A1 Solid forms of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses |
| 01/15/2014 | EP2683694A1 Androgen receptor antagonists and uses thereof |
| 01/15/2014 | EP2683693A1 Rorgammat inhibitors |
| 01/15/2014 | EP2683690A1 Quinolinone derivatives |
| 01/15/2014 | EP2683689A1 Fluoro-pyridinone derivatives useful as antibacterial agents |
| 01/15/2014 | EP2683687A1 Primary amine diazeniumdiolate heterocyclic derivatives |
| 01/15/2014 | EP2683380A2 Heavy-duty vehicle brake assembly with sealing interface |
| 01/15/2014 | EP2683244A1 Heterocyclic modulators of lipid synthesis |
| 01/15/2014 | CN203389617U Melting reaction production equipment |
| 01/15/2014 | CN103517900A Fungicide hydroximoyl-tetrazole derivatives |
| 01/15/2014 | CN103517896A Quinolinone derivatives |
| 01/15/2014 | CN103509008A Derivatives of pyrazole-substituted amino-heteroaryl compounds |
| 01/15/2014 | CN103509007A Flumatinib mesylate crystal form and preparation method and use thereof |